You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PR073/#425  Senaparib, a PARP inhibitor, in patients with BRCA1/2 mutated platinum sensitive recurrent ovarian cancer: subgroup analysis from Sabrina study

Article metrics

Article menu

Download PDFPDF

Featured Posters: Poster Rounds with the Professors
AS11. Ovarian cancer
PR073/#425  Senaparib, a PARP inhibitor, in patients with BRCA1/2 mutated platinum sensitive recurrent ovarian cancer: subgroup analysis from Sabrina study
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to October 2024

AbstractFullPdf
Nov 202359014
Dec 20233508
Jan 20241601
Feb 20243001
Mar 20241805
Apr 20241102
May 20241602
Jun 20241900
Jul 2024403
Aug 20241102
Sep 20241900
Oct 2024200
Total240038